Alkermes Investigational Site is a clinical research site located in Columbus, Ohio, United States 43221.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Alkermes Investigational Site has participated in 2 clinical trials.
Therapeutic areas: Relapsing Remitting Multiple Sclerosis, Multiple Sclerosis.
Sponsors: Biogen.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Alkermes Investigational Site has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Alkermes Investigational Site has 2 clinical trials on record. Their work covers Relapsing Remitting Multiple Sclerosis, Multiple Sclerosis.
Alkermes Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.